Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acipimox for Insulin Resistance and Vascular Dysfunction in Type 1 Diabetes
NCT01816165Phase 3Completed
- Sponsor
- University of Colorado Denver
- Start
- Jun 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acipimox in type 1 diabetes mellitus (T1D), sponsored by University of Colorado Denver. Started Jun 2011; status: completed.
02
Drugs
acipimox
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01816165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01816165.